OneMedNet pivots to iRWD but has $122 cash and substantial doubt about going concern

Company: OneMedNet Corporation (NASDAQ: DKDCU)

Short summary: Management pivoted from the BEAM subscription business to focus on iRWD (web imaging / real-world data). The company reduced some legacy liabilities by converting debt to equity and completed private placements, and it holds Bitcoin as a liquid asset. But cash is critically low and operating losses persist - the 10‑Q discloses substantial doubt about the company's ability to continue as a going concern.

Facts & key statistics (reported amounts are in thousands, except share counts):

* Cash and cash equivalents: $122 (June 30, 2025)

* Investment in crypto assets - Bitcoin: fair value $1,598; units held 15; cost basis $1,636

* Total current assets: $2,267; Total assets: $2,337

* Total current liabilities: $6,159; Total liabilities: $6,177

* Stockholders' deficit: $(3,840) (improved from $(15,950) at Dec 31, 2024)

* Accumulated deficit: $(100,489)

* Shares issued/outstanding: 46,283,392 issued (46,095,647 outstanding as of Aug 12, 2025)

* Three months ended June 30, 2025 (Q2 2025): Subscription revenue $47; Web imaging revenue $108; Total revenue $155

* Q2 2025 cost of revenue: $396 → gross margin (loss) $(241)

* Q2 2025 operating expenses: $1,822; loss from operations $(2,063)

* Q2 2025 other income (net): $(5,045) resulting largely from fair-value marks, realized crypto gains and gains on troubled debt restructurings

* Q2 2025 net income: $2,982; basic EPS $0.07 (weighted avg shares basic 36,835,945)

* Six months ended June 30, 2025: Total revenue $292 (down 39% vs. 2024 six months); cost of revenue $737; operating loss $(4,351); net income $1,080

* Six‑month cash flow highlights: net cash used in operating activities $(4,232); net cash provided by financing activities $2,932 (private placements & related-party subscriptions net ~ $3.7M); investing activities net +$1,250 (crypto trading)

* One-time / non-cash items materially affecting results: gain on troubled debt restructurings $3,707; change in fair value of PIPE Notes $(1,221) and Yorkville Note $(64); realized bitcoin gain $(844) (six months)

Positive takeaways

* Management executed liability-to-equity conversions and private placements that materially reduced some debt balances (PIPE notes, Yorkville conversions, loan conversions), improving balance sheet structure and reducing interest expense.

* iRWD (web imaging) revenue grew (Q2 web imaging +26% YoY; six months +40% YoY) - the strategic focus is on higher-margin RWD sales.

* Realized crypto activity generated cash and non-cash gains during the period (sales proceeds and mark-to-market contributed ~$0.8M realized gain and unrealized adjustments).

Negative / risk items (income statement and liquidity)

* Core operations are unprofitable: cost of revenue vastly exceeded revenue (costs = 255% of revenue in Q2 2025), producing negative gross margins - the business is still loss-making before other income.

* Net income in the quarter was driven by non‑operational items (fair‑value adjustments, debt restructuring gains and crypto marks). That means the appearance of profitability is not from core recurring operations.

* Revenue declined significantly due to decommissioning BEAM (subscription revenue fell 67% in Q2 and 69% for six months). Management stopped renewals during the transition.

* Liquidity is precarious: only $122 cash on hand and Bitcoin is being used as a liquidity source; company states cash + Bitcoin are not adequate to fund operations for 12 months → going concern flagged.

* Heavy reliance on related‑party financing and equity issuances caused dilution (multiple conversions and private placements issued millions of shares during the period).

* Material weaknesses in internal controls noted (user access/segregation of duties, record keeping, controls around non‑routine transactions).

Straightforward conclusion

OneMedNet (NASDAQ: DKDCU) is mid‑pivot: it has cut a legacy subscription product (BEAM) and is pushing iRWD revenue, and management has actively reduced debt via equity conversions and private placements. Those moves improved the balance sheet and generated one‑time accounting gains, producing reported net income for the quarter. However, core operations remain loss-making, cost of revenue is out of line with sales, cash on hand is critically low ($122), and the company explicitly warns of substantial doubt about its ability to continue as a going concern. Watch near‑term cash runway, further dilution, and whether iRWD can scale to deliver sustainable, positive operating margins.

What to monitor next: cash balance and cash burn, further crypto sales vs. price volatility, execution and revenue traction for iRWD, any additional equity or debt raises, and remediation of internal control weaknesses.